Charles S. Ryan, Director at BioRestorative Therapies, Inc. (BRTX), bought 200,000 shares at $0.25 ($50K) on 2015-05-08, disclosed to the SEC on 2015-05-12.
Open-market purchase of $50k BRTX by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| Filing → |